OrbiMed RCO IV Offshore Feeder, LP is a private equity fund based in New York, New York. According to its most recent Form D, filed Dec 16, 2022, it has sold $344,450,400 of interests to 18 investors since its first sale in Jul 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include C. Stevens; Geoffrey Hsu; Carl Gordon.
- Total raised
- $344,450,400Cumulative sales reported on Form D
- Investors
- 18
- First sale
- Jul 15, 2022
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- C. Stevens; Geoffrey Hsu; Carl Gordon
- Latest Form D
- Dec 16, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Dec 16, 2022 | Form D/A (amendment) | $344,450,400 | 18 | SEC.gov ↗ |
| Jul 14, 2022 | Form D | $0 | 0 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 14, 2022. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about OrbiMed RCO IV Offshore Feeder, LP
What is the minimum investment for OrbiMed RCO IV Offshore Feeder, LP?
OrbiMed RCO IV Offshore Feeder, LP's latest Form D, filed Dec 16, 2022, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in OrbiMed RCO IV Offshore Feeder, LP?
OrbiMed RCO IV Offshore Feeder, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has OrbiMed RCO IV Offshore Feeder, LP raised?
OrbiMed RCO IV Offshore Feeder, LP reports $344,450,400 sold from 18 investors on its Form D filed Dec 16, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is OrbiMed RCO IV Offshore Feeder, LP based?
OrbiMed RCO IV Offshore Feeder, LP is based in New York, New York.
When did OrbiMed RCO IV Offshore Feeder, LP launch?
OrbiMed RCO IV Offshore Feeder, LP reports its first sale in Jul 2022.
Size compared with every private equity fund
Raised more than 88% of the 3,677 private equity funds based in New York, and more than 86% of all 9,002 that report sales.